Bupropion Price Trend

Bupropion Price Trend, Index and Forecast

Track the latest insights on bupropion price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Bupropion Prices Outlook Q2 2025

• USA: US$ 77420/MT
• China: US$ 72200/MT
• Germany: US$ 84010/MT
• Canada: US$ 84890/MT
• Brazil: US$ 91080/MT

Bupropion Price Chart

Get real-time access to monthly/quaterly/yearly prices, Request Sample

During the second quarter of 2025, the bupropion prices in the USA reached 77420 USD/MT in June. As per the bupropion price chart, the rising prices for key inputs, complex manufacturing processes pushed production costs upward, laying upward pressure on overall pricing. Besides, trade disruptions and shipping delays added costs and unpredictability, weakening supply stability and encouraging price increases.

During the second quarter of 2025, the bupropion prices in China reached 72200 USD/MT in June. Container freight benchmarks stabilized in Q2, taking some pressure off export-linked supply chains for pharmaceutical intermediates and packaging. Lower freight bills reduced the delivered cost base. Besides, regulatory factors maintained a weight too. Policy-driven limitations, manufacturing compliance hurdles, and distribution restrictions added friction to supply and impacted pricing.

During the second quarter of 2025, bupropion prices in Germany reached 84010 USD/MT in June. Prices in Germany were shaped mainly by the country’s reference price system. Moreover, strong competition from other generic brands and parallel imports kept retail prices close to the set reference price, with little room for manufacturers to push them higher. Overall, prices were kept in check by regulation, insurer contracts, competition, and policies to protect supply.

During the second quarter of 2025, the bupropion prices in Canada reached 84890 USD/MT in June. Growing awareness of mental health issues and stronger smoking‑cessation initiatives propelled demand for bupropion HCL. That surge exerted upward pressure on prices, as pharmacies faced heightened consumer interest alongside steady production capacity. Patent expirations and the entry of multiple generics had started to counteract those price hikes. Competition increased among manufacturers and retailers, which helped soften the cost burden on patients and prevented runaway pricing despite strong demand.

During the second quarter of 2025, the bupropion prices in Brazil reached 91080 USD/MT in June. Bupropion prices in Brazil were shaped by a combination of rising demand, growing generic competition, and ongoing pharmaceutical innovation. The expanding use of bupropion for both depression and smoking cessation intensified purchasing activity from pharmacies and healthcare providers. Public health initiatives promoting smoking reduction and greater recognition of mental health conditions also kept demand high. This consistent upward pull on consumption put pressure on supply chains, encouraging suppliers to maintain competitive pricing strategies to capture market share.

Bupropion Prices Outlook Q2 2023

• USA: US$ 72900/MT
• China: US$ 73300/MT
• Germany: US$ 77500/MT

In the second quarter of 2023, the price of the bupropion in the United States reached 72900 USD/MT by June. Similarly, in China, the bupropion prices hit 73300 USD/MT in the same month. Germany also saw bupropion prices reaching 77500 USD/MT during Q2 2023.

Regional Coverage

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the bupropion prices.

Global Bupropion Price Trend

The report offers a holistic view of the global bupropion pricing trends in the form of bupropion price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price levels but also provides insights into historical price of bupropion, enabling stakeholders to understand past fluctuations and their underlying causes. The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed bupropion demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Bupropion Price Trend

Q2 2025:

Bupropion prices in Europe reflected the combined effects of heightened demand, competitive market forces, and ongoing product development. The sustained rise in prescriptions for both depression treatment and smoking cessation continued to drive strong purchasing activity across multiple healthcare systems. Public awareness campaigns on mental health and anti-smoking measures maintained steady pressure on supply channels, prompting suppliers to balance availability with competitive pricing to retain market position. The expansion of the generic segment after patent expirations remained a central factor in shaping price movements. With more generic manufacturers operating in the region, procurement processes, especially within national health services, became more competitive, leading to broader access and downward pressure on market prices. Large-scale tenders and centralized purchasing policies in certain countries amplified this effect, as suppliers competed for contracts that would secure volume sales.

Q2 2023:

European bupropion prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed bupropion price information for a comprehensive list of countries.

North America Bupropion Price Trend

Q2 2025:

As per the bupropion price index, manufacturers responded to growing demand from the pharmaceutical sector by leaning on imports, since domestic production remained limited. That made them more exposed to price swings in global raw material markets and the logistics needed for transport. Global supply chain disruptions and shifts in trade policy added tension to the market, reinforcing cost pressures as transporting and sourcing materials got more complex. Besides, manufacturing cost increases, stemming from raw material availability and production constraints, further nudged prices upward. Those cost pressures were felt most keenly by US buyers reliant on external suppliers.

Q2 2023:

The analysis of bupropion prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific bupropion historical data within the United States and Canada can also be provided.

Middle East and Africa Bupropion Price Trend

Q2 2025:

The report explores the bupropion trends and bupropion price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

Q2 2023:

The report explores the bupropion pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on bupropion prices for countries can also be provided.

Asia Pacific Bupropion Price Trend

Q2 2025:

Market prices were shaped largely by supply‑chain frictions. Freight carriers faced softer demand for containers, yet costs rose on account of disruptions like rerouting and shipping lanes remained volatile due to geopolitical tensions and extended routes. This fluctuation exerted upward pressure on drug supply logistics across Asia‑Pacific. Regulatory oversight tightened in key manufacturing hubs. Raw material shortages also played their part. Inputs feeding into bupropion synthesis, such as precursor chemicals, faced intermittent bottlenecks.

Q2 2023:

The bupropion pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This bupropion price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Bupropion Price Trend

Q2 2025:

As per the bupropion price index, demand signals were steady to firm across antidepressants, and market trackers highlighted renewed attention on mood disorder treatments. This backdrop supported negotiating positions for some suppliers, even as competitive tendering kept caps in place in public channels. Besides, product-specific monitoring pointed to cautious sentiment around bupropion itself. Pricing services referenced prior swings tied to production costs, shipping, and compliance events, and buyers in the region priced these risks into contracts during Q2.

Q2 2023:

The analysis of bupropion prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Bupropion Price Trend, Market Analysis, and News

IMARC's latest publication, “Bupropion Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the bupropion market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of bupropion at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed bupropion prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting bupropion pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

Bupropion Industry Analysis

The global bupropion market size reached USD 1.48 Billion in 2024. By 2033, IMARC Group expects the market to reach USD 2.41 Billion, at a projected CAGR of 5.32% during 2025-2033.

• The increasing awareness and diagnosis of mental health conditions, including major depressive disorders and seasonal affective disorders, are driving the demand for effective treatment such as bupropion. According to the World Health Organization (WHO), an estimated 3.8% of the population experience depression, including 5% of adults (4% among men and 6% among women), and 5.7% of adults older than 60 years. Approximately 280,000,000 people in the world have depression. Depression is about 50% more common among women than among men. Worldwide, more than 10% of pregnant women and women who have just given birth experience depression.
• According to industry reports, approximately 5% of the US population experiences seasonal depression in any given year. Four out of five people with seasonal depression are women. The average age of onset is between 20 and 30 years old.
• The market for bupropion is driven by its effectiveness in helping smoking cessation as a public health initiative and individual efforts to quit smoking, which is boosting its demand. According to the data from the American Lung Association, smoking-related diseases claim more than 4,80,000 lives in the US each year. Smoking costs the US at least $289 billion each year, including at least $151 billion in lost productivity and $130 billion in direct healthcare expenditures. According to the report by CDC, nearly 70% of adults who smoke say they want to quit. Over 50% of adults who smoke try to quit each year. Three in five adults who ever smoked cigarettes have quit.
• The availability of a generic version of bupropion is making it more affordable and accessible, which is increasing its demand. According to the FDA, it is estimated that 91% of all prescriptions in the United States are filled as generic drugs, with more than 32,000 generic drugs approved by the FDA to date. For instance, a recent FDA study showed the savings accrued during the first year after approval for new generic drugs approved in 2018, 2019, and 2020 to be approximately $53.3 billion. This means tens of billions of dollars were saved each of those years, economy-wide, from new generic approvals.

Bupropion News

The report covers the latest developments, updates, and trends impacting the global bupropion industry, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in bupropion production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the bupropion price trend.

Latest developments in the bupropion industry:

• In February 2022, Drug Granules India received approval from the US health regulator to market Bupropion hydrochloride extended-release tablets, and antidepressant medication, in the American market.
• In August 2022, the Food and Drug Administration (FDA) approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults. PPD is a major depressive episode that typically occurs after childbirth but can also begin during the later stages of pregnancy.

Product Description

Bupropion refers to an atypical antidepressant medication majorly utilized to treat major depressive disorder (MDD) and seasonal affective disorder (SAD). In addition to this, this medication is also prescribed to help in smoking cessation.

Unlike other antidepressants, bupropion does not fit neatly into the categories of selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors. Instead, it majorly inhibits the reuptake of norepinephrine and dopamine, increasing their levels in the brain. This unique mechanism of action makes bupropion useful for patients who do not respond well to traditional antidepressants.

Bupropion is marketed under different brand names such as Zyban and Wellbutrin. In line with this, it is generally well-tolerated, though, side effects include dry mouth, headaches, and insomnia. Bupropion’s lower risk of sexual side effects compared to SSRIs adds to its appeal.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of bupropion pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting bupropion price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The bupropion price charts ensure our clients remain at the forefront of the industry.